Barclays PLC

Barclays PLC and related entities are no longer subject to Section 16 reporting requirements due to the unwind of certain stock borrow and repurchase transactions related to Pyxus International, Inc.

Barclays PLC reports that they are no longer subject to Section 16 reporting requirements due to the return of certain stock borrow and repurchase transaction activity that did not create a pecuniary interest in Sun Country Airlines Holdings, Inc. securities.

Barclays PLC and related entities are no longer subject to Section 16 reporting requirements due to the unwind of certain stock borrow and repurchase transactions related to FrontView REIT, Inc.

Barclays PLC reports it is no longer subject to Section 16 reporting requirements due to the unwind of certain stock borrow and repurchase transaction activity that did not create a pecuniary interest in the securities of Launch One Acquisition Corp.

Barclays PLC reports it is no longer subject to Section 16 reporting requirements due to the unwind of certain stock borrow and repurchase transaction activity.

Barclays PLC reports it is no longer subject to Section 16 reporting requirements due to the unwind of certain stock borrow and repurchase transaction activity that did not create a pecuniary interest in the securities of Global Star Acquisition Inc.

Barclays Plc reported 10,915 holdings worth $500.2B for the period ended September 30, 2026.

Barclays Plc reported 11,383 holdings worth $520.8B for the period ended June 30, 2026.

Barclays PLC filed an amended 13F report, correcting its Q3 2025 holdings to reflect a $461.23 billion portfolio across 11,877 positions.

Barclays PLC has filed an amendment to its Q3 2024 13F-HR report, restating holdings to reflect exact dollar values instead of thousands.

Barclays PLC has filed an amendment to its Q1 2023 13F report, correcting previously reported holding values from thousands to exact dollar amounts without changing positions.

Barclays PLC has filed an amendment to its Q2 2023 13F report, restating holding values from thousands to exact dollar amounts without changing positions.

Barclays PLC has filed a Schedule 13G, disclosing a beneficial ownership of 870,255 shares, representing 4.81% of the outstanding common stock of Crown Reserve Acquisition Company.

Barclays PLC has filed an amendment to its Schedule 13G, reporting a beneficial ownership of 7,233 shares, representing 0.02% of Cartesian Therapeutics Inc.'s common stock.

Barclays PLC has updated its beneficial ownership filing for JELD-WEN Holding Inc., reporting a 6.86% stake as of September 30, 2026.

Barclays PLC has filed an amendment to its Schedule 13G, reporting beneficial ownership of 4.00% of Mercer International Inc.'s common stock as of September 30, 2026.

Barclays PLC has updated its beneficial ownership filing for Penumbra Inc., reporting a 4.82% stake as of September 30, 2026.

Barclays PLC has updated its Schedule 13G filing to report beneficial ownership of 7.16% of Office Properties Income REIT's common stock.